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ABSTRACT: Escherichia coli (E.coli) is a common bacterium that can be naturally found in the intestinal tract of 
birds and as a result in their environment. However, it can cause clinical disease called colibacillosis which is regarded 
as one of the most common and important diseases in poultry. Strains of E.coli that have the ability to cause clinical 
disease are described as Avian Pathogenic Escherichia Coli (APEC). Colibacillosis can affect birds of all ages and 
different types of poultry production including broiler and commercial layers and breeders. The ability of E.coli to 
cause colibacillosis is not always the same; that is why its role as primary or secondary pathogen triggered by various 
predisposing factors is contradictory and differs from case to case. Antibiotics have been used as the main tool against 
colibacillosis for many decades. However, the emergence of increased antibiotic resistance has posed the need of al-
ternative treatment to colibacillosis as well as emphasizing on preventive measures to avoid disease. Τhe scope of this 
article is to assess recent scientific literature data on avian colibacillosis emphasizing on disease characteristics and 
recent data on prevention and control of the disease.
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INTRODUCTION
Escherichia coli (E.coli) is a bacterium that causes disease in different animal species, mainly local-
ized in the intestine of mammals, but also they can 
cause septicemic or special type disease like ‘Oedema 
disease’ in pigs and ‘watery mouth in calves’ (Quinn 
et al., 2011; Tseng et al., 2014; Bashahun and Amina, 
2017; Luise et al., 2019). Poultry is also affected by 
E.coli which causes serious clinical disease named 
colibacillosis. Those E.coli strains are called avian 
pathogenic Escherichia coli (APEC) and more often 
they can cause disease outside of the intestinal tract 
in poultry (extraintestinal APEC) (Dho-Moulin and 
Fairbrother, 1999; Ewers et al., 2009).
Escherichia coli is described as the most frequent 
bacterial agent that causes general health and produc-
tion problems in poultry (Barnes et al., 2008; Kabir, 
2010; Zhuang et al., 2014; Landman and van Eck, 
2015). 
 Avian pathogenic E.coli strains seem to have re-
stricted role in causing clinical disease in humans. 
However, some human uropathogenic E.coli strains 
are found to share similar genetic factors with APEC 
indicating a relationship between them (Skyberg et 
al., 2006; Ewers et al., 2007; Zhu Ge et al., 2014; 
Stromberg et al., 2017; Jorgensen et al., 2019). Fur-
thermore, APEC antibioresistance can be a source of 
resistance for human pathogens (Singer and Hofacre, 
2006; Johnson et al., 2007; Mellata, 2013; Singer, 
2015). 
The aim of this article is to provide important 
recent information concerning epidemiology, inci-
dence, prevention and control of colibacillosis to any-
one concerned in research or poultry production.
MICROBIOLOGY
Escherichia coli is a bacterium that belongs to the 
family of Enterobacteriacae. The family consists of 
many different important pathogenic genera like Sal-
monella and Yersinia and other members that can act 
like opportunistic pathogens (Enterobacter, Citro-
bacter, Proteus etc) (Quinn et al., 2011). Bacteria of 
the Escherichia genus are Gram negative rods, with a 
flagella or not, that can grow under aerobic or anaer-
obic conditions. They have the ability to ferment dif-
ferent sugars like glucose and lactose; however, some 
strains do not ferment lactose, they are oxidase neg-
ative and indole positive (Barnes et al., 2008; Quinn 
et al., 2011). 
Their colony morphology varies according to the 
medium that is used for culturing and the biochemical 
properties of the strain. For example, in MacConkey 
agar they have a pink appearance because of lactose 
fermentation and the production of acid, with the ex-
ception of a few non-lactose fermenting strains that 
are orange-pale strains (Filho et al., 2013). 
The classification of various strains in different 
serotypes is based on 3 different antigens found in 
the bacterial cell of Escherichia coli: the O antigen 
(described as somatic antigen from the Greek word 
‘soma’ that means ‘body’) that consists of polysac-
charides (Stenutz et al., 2006), the H antigen that is 
cited on the flagella (flagellar antigen) and the K anti-
gen (capsular antigen) (Brugere-Picoux et al., 2015). 
Up to now, about 180 somatic antigens, 60 flagellar 
and 80 capsular antigens have been reported. 
The ability of certain E.coli bacteria to cause dis-
ease has been attributed to certain serogroups. 
DISTRIBUTION
A big variety of serogroups/serotypes have been 
isolated from birds that were suffering from clinical 
colibacillosis with different patterns according to 
country/region using mainly the agglutination meth-
od and pulsed-field gel electrophoresis (PFGE). The 
agglutination method is a classical and simple method 
for serotyping E.coli strains (Orskov et al., 1977; Βet-
telheim and Thompson, 1987; Fratamico et al., 2016). 
The technique of PFGE is the most commonly used 
one to study the molecular epidemiology of infectious 
pathogens such as Escherichia coli, Streptococcus 
spp., Staphylococcus spp., Neisseria meningitides, Vi-
brio cholerae, Bordetella pertussis and Campylobac-
ter jejuni (Ahmed et al., 2012; Natsos et al., 2019). 
A big number of different serogroups were isolated 
from septicemic birds in Spain (Blanco et al., 1998). 
In a study conducted in Canada, 14 different serotypes 
were reported while most of the strains were untypea-
ble (Allan et al., 1993). The O111 serogroup has been 
involved with polyserositis in layers in Italy (Zanella 
et al., 2000); furthermore, the O111 along with O166 
and O64 were predominant isolates from egg perito-
nitis in layers in a study conducted in India (Srini-
vasan et al., 2013) while O111 with O78 were isolated 
from layer flocks in USA and Greece (Trampel et al., 
2007; Koutsianos et al., 2017). A huge diversity of 
serotypes was revealed in a European study investi-
gating the characteristics of APEC isolates from UK, 
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Italy and Germany (Cordoni et al., 2016). Heydel et 
al. (2019a) investigated the characteristics of E.coli 
strains isolated from broiler and layer chickens from 
Germany, Hungary, Belgium and the Netherlands. 
They reported that the majority of isolates (42.2%) 
belonged to various serogroups followed by O78 
(27.5%), O2 (25%) and O1 (5.9%). A wide diversi-
ty of serotypes was also reported by Ali et al. (2019) 
for APEC strains of different geographical areas in 
Egypt. Different serotypes (O78, O1, O2, O86, O63, 
O125, O27, O169) were also found to be predominant 
in different country regions. In Brazil, the O6 sero-
group was reported as the most prevalent serogroup in 
APEC isolates from broiler farms (Knobl et al., 2012) 
while the O2, O53 and O78 were found to be the pre-
dominant E.coli serogroups in a recent research pro-
ject in Korea (Kim et al., 2020).
In general, the most described serogroups that are 
reported to cause clinical disease in poultry are O1, 
O2, O35, O36 and O78 (Barnes et al., 2008). The 
prevalence of 3 serogroups (O78, O2, O1) in birds suf-
fering from colibacillosis has been reported in many 
studies (Ngeleka et al., 1996; Ewers et al., 2004; Mc 
Peake et al., 2005; Zhao et al., 2005; D’Incau et al., 
2006; Camarda et al., 2008; Wang et al., 2010; Wun 
Jeong et al., 2012; Dou et al., 2016). 
Two different research projects performed in broil-
ers with coliseptisemia in the USA, have referred the 
O78 as the most common serogroup among others 
isolated from samples (Ngeleka et al., 1996; Zhao et 
al., 2005). 
 A German study, using coliseptisemic birds (lay-
ers and broilers), found that 49.6% of the isolated 
E.coli strains belonged to 3 serotypes (O2:28.7%, 
O78:14.7%, O1:6%) (Ewers et al., 2004). A similar 
research project conducted in coliseptisemic broilers 
and layers in the UK, revealed that the majority of 
E.coli isolates belonged to the O78 serogroup (45.6%) 
while 14.9% belonged to the O2 serogroup (Mc Peake 
et al., 2005). 
An Italian study that focused on colibacillosis in 
layers reported that the 3 most common serogroups 
of the isolates were O78 (49%), O88 (15%) and O2 
(9%) (D’Incau et al., 2006). A second Italian survey 
in layers revealed a variety of 15 serotypes, with the 
O78, O2 and O129 being the most dominant while a 
45.4% remained untypeable (Camarda et al., 2008). 
A south Korean study reported O78 as the most 
common group (19.4%) for E.coli isolates coming 
from diseased poultry with colibacillosis (Wun Jeong 
et al., 2012) while Chinese researchers revealed that 
the two most common groups for Escherichia coli 
isolated from birds suffering from colibacillosis were 
the O78 (35.8%) and the O2:14.4% groups (Dou 
et al., 2016). Another survey that was conducted in 
Southern China in broilers suffering from colibacil-
losis identified E.coli isolates that belonged to 21 
different serogroups. The most prevalent serogroups 
among strains were the O65 (27%), O78 (10%) and 
the O8 (9%) groups (Wang et al., 2010).
Finally, in a French survey, the most important 
E.coli serogroups isolated from colibacillosis cas-
es in poultry were O78:17.6%, O2:17.3%, O18:9%, 
O1:6%, O5:4.5% and O8:2% (Schouler et al., 2012). 
ROUTES OF INFECTION
 Escherichia coli is a natural inhabitant of the 
poultry intestinal tract. It returns in the bird environ-
ment through droppings and can insert to other birds 
by the oral-feacal route (Dho-Moulin and Fairbrother, 
1999). It seems that bird’s intestine and environment 
are the most important reservoirs for Escherichia coli 
strains capable of causing infection (Ewers et al., 
2009). This study reported that E.coli strains isolat-
ed from the intestine of healthy birds and from their 
environment are phylogenetically similar to APEC 
strains that have been isolated from coliseptisemic 
birds. Therefore, they have the zoonotic potential to 
cause colibacillosis in poultry (Ewers et al., 2009; 
Kabir, 2010). Vectors like darkling beetle (Goodwin 
and Waltman, 1996), flies, insects, mites (Wales et 
al., 2010), rats and wild birds can play a role in the 
spreading of Escherichia coli (Barnes et al., 2008). 
Escherichia coli can be transmitted either horizontal-
ly, directly or indirectly, or vertically from breeders 
carrying the organism in their reproductive tract to 
their progeny (Giovanardi et al., 2005). 
The respiratory route seems to be also very impor-
tant for the appearance of clinical disease, while the 
oviduct can also be another route of infection for Es-
cherichia coli concerning layers and breeders (Antao 
et al., 2008; Ozaki and Murase, 2009; Landman et al., 
2013). Finally, penetration of E.coli through the skin 
can produce an inflammation in the form of cellulitis 
(Norton et al., 2000).
VIRULENCE FACTORS
The ability of APEC to cause disease has been 
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identified in specific genes which are responsible for 
coding the production of specific components of the 
bacterial cell, the virulence factors. These factors can 
either increase the ability of E.coli to attach to the host 
cells, increase the bacterium ability to multiply and 
attack the bird cell or can protect E.coli against the 
immune response of the host (Dho-Moulin and Fair-
brother, 1999). 
The most important virulence factors described 
in E.coli bacteria cells are adhesins like the type 1-F 
adhesin (La Ragione and Woodward, 2002) and the 
P-adhesin , iron related factors, like aerobactin sys-
tem consisting of iuc, iut factors (Dziva and Stevens, 
2008), protectins like the K1 and the iss factor (Mel-
lata, 2013), invasins like ibeA (Cortes et al., 2008; 
Flechard et al., 2012), toxins/bacteriocins like stx1,2, 
hlyD and hlyF and miscellaneous factors (Barnes et 
al., 2008).
However, despite the fact that many specific vir-
ulence factors and their genes have been described, 
there is not a certain pattern attributed to APEC 
strains (La Ragione and Woodward, 2002). Different 
factors and combinations can be present in different 
avian pathogenic Escherichia coli strains. Ewers et al. 
(2004) reported a wide diversity of virulence genes 
combinations for isolates that belonged to O78, O1 
and O2 serogroups, while strains that belonged to 
other serogroups had a higher variability. Schouler et 
al. (2012) reported that 13 virulence genes are more 
often present in APEC strains and 4 specific virulence 
gene combinations can be linked with the identifica-
tion of APEC strains. However, it was found that 30% 
of the strains could not be confirmed as pathogenic 
because of the presence of different virulence factors 
that contributed in the strain pathogenicity. Guabiraba 
and Schouler (2015) also reported that although some 
virulence gene patterns can help us determine the 
pathogenicity of APEC strains, certain virulence gene 
combinations cannot be used in general to describe 
APEC strains. Furthermore, the presence of virulence 
factors patterns that are observed in APEC strains can 
also be present in nonpathogenic E.coli strains (Dziva 
and Stevens, 2008). 
CLINICAL DISEASE 
Ε.coli can infect and damage different bird sys-
tems causing various syndromes and localised or sys-
temic disease. 
In day old chicks, a very common type of E.coli 
infection is the yolk sack infection (omphalitis) which 
is characterized by inflammation of the yolk sack and 
high mortality (Dinev, 2007). 
In birds of different ages, E.coli can cause severe 
infection of the upper or lower respiratory system 
through the nasal route or the trachea. In cases of 
localised infection of the upper respiratory system, 
facial oedema and sinuses swelling can be presented 
and described as swollen head syndrome. However, 
in case of lower respiratory infection, colibacillosis 
is characterized by the presence of fibrinous whitish 
yellow exudates in the air sacks and fibrinous pneu-
monia (Barnes et al., 2008). Another type of localized 
colibacillosis is cellulitis that is characterized by in-
flammation of the skin and presence of subcutaneous 
fibrinous exudates especially in broilers. Cellulitis is 
a very common reason for carcass condemnations in 
the slaughterhouse (Norton, 1997).
In layers and breeders, the most common type of 
colibacillosis is the infection of reproductive system; 
which is known as salpingitis, oophoritis and perito-
nitis (Jordan et al., 2005; Barnes et al., 2008; Bru-
gere-Picoux et al., 2015). Regarding the macroscop-
ic findings in necropsy, fibrin in different quantities 
can be present inside the peritoneum, the oviduct 
or around the ovaries (Dinev, 2007). Egg peritoni-
tis syndrome caused by APEC is of great economic 
significance in layer production because of its high 
incidence, the induced flock mortality and drop in 
egg production (Landman et al., 2013). Furthermore, 
there is an added cost of flock antibiotic treatment. In 
males, E.coli infection can cause reduced fertility due 
to testicles inflammation (Barnes et al., 2008)
The septicemic or systemic form of colibacillosis 
is mainly found in broilers but can also be present in 
layers. It is characterized by polyserositis and pres-
ence of fibrin in various organs (pericarditis, peri-
hepatitis, air-sacculitis, peritonitis) (Randall, 1985; 
Dinev, 2007). If birds survive the acute phase of coli-
septisemia, colibacillosis can revert into a chronic lo-
calized type of disease. In such cases, coli infection 
can be present in unusual sites like brain, eyes, joints 
and bones (Barnes et al., 2008). 
 Another type of systemic colibacillosis is report-
ed as Hjarre disease or coligranuloma. This type of 
colibacillosis is caused by specific E.coli strains and 
appears as multiple granuloma like lesions in various 
organs like liver, proventriculous and intestine. Col-
igranuloma is rarely seen but mortality rates in these 
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cases can be high (Brugere-Picoux et al., 2015). How-
ever, there is a new claim regarding a different aeti-
ological agent responsible for granuloma disease in 
poultry. Landman and Van Eck (2017a) reported that 
in many case that granuloma disease was present, it 
was not possible to isolate E.coli or reproduce exper-
imentally the granuloma lesions. They revealed that 
the role of a parasite, Tetratrichomonas gallinarum 
that has the ability to cause granulomatosis should be 
taken into consideration. This parasite has been isolat-
ed in cases of granuloma disease in poultry (Landman 
et al., 2019). 
INTERACTION OF E.COLI WITH OTHER IN-
FECTIOUS AND NON INFECTIOUS AGENTS
Αs it was mentioned before, E.coli is a bacterium 
can be related to other diseases. However, its role can 
differ from case to case, acting individually as a pri-
mary causative agent or act as a secondary pathogen 
complicating other viral, bacterial or parasitic disease 
as well as bad environmental management (Barnes et 
al., 2008).
Respiratory viruses such as paramyxovirus (New-
castle disease) (El Tayeb and Hanson, 2002), coro-
navirus (Infectious bronchitis) (Matthijs et al., 2003; 
Dwars et al., 2009), metapneumonivirus (Avian rhi-
notracheitis-swollen head syndrome) (Nakamura et 
al., 1997; Al-Ankari et al, 2001), herpesvirus (Infec-
tious laryngotracheitis) (Nakamura et al., 1996), or-
thomyxovirus (Avian influenza) (Mosleh et al., 2017; 
Samy and Naguib, 2018) can trigger avian colibacil-
losis. Bacterial causes like Mycoplasma gallisepticum 
(Bradbury, 2005; Barnes et al., 2008) or Mycoplasma 
synoviae (Raviv et al., 2007) can also be complicat-
ed with E.coli creating serious respiratory syndromes 
with severe adverse effects on the birds. Those infec-
tious agents can either damage the upper respiratory 
system cilia which is a significant defensive mecha-
nism against E.coli penetration or act as immunosup-
pressive agents (Guabiraba and Schouler, 2015).
Immunosuppressive viruses as Birnavirus (Infec-
tious bursal disease) and circovirus (chicken infec-
tious anaemia) can predispose a secondary infection 
with E.coli (Gowthaman et al., 2012; Umar et al., 
2017). 
Apart from the aforementioned infectious agents, 
the environmental factors are well established to play 
a crucial role as a risk factor for horizontal disease 
transmission (Natsos et al., 2016). Some important 
non infectious factors that are predisposing to coli-
bacillosis are shown in Table (1).
Table 1. Non infectious predisposing risk factors related to colibacillosis in poultry
RISK FACTORS REFERENCE
Air quality/ammonia level/ventilation Patterson and Adrizal, 2005
Water quality Amaral, 2004; Dhillon & Jack,1996
Vaccination stress Friedman et al., 1992; Nakamura et al., 1994; Matthijs et al., 2009
Bird density Vandekerchove et al., 2004
Distance between poultry farms Vandekerchove et al, 2004
Temperature/heat stress Omer et al., 2010
Productive period/peak of lay Zanella et al., 2000
Hatchery hygiene Hill, 1994; Samberg and Meroz, 1995
TREATMENT USING ANTIMICROBIALS-
ANTIBIOTIC RESISTANCE
Antimicrobials have been used for many decades 
as a tool against colibacillosis. However, E.coli like 
many other bacteria have the ability to create anti-
biotic resistance under the pressure of antibiotic us-
age (Aarestrup and Wegener, 1999). This resistance 
is created when antibiotics are used extensively on a 
prophylactic schedule or when antibiotic treatment is 
applied incorrectly using an underdosage (OIE, 2016). 
The creation of antibiotic resistance is based on 
the ability of bacteria to change the composition of 
their outer membrane, to produce enzymes that dam-
age antimicrobials or alter their metabolism (Quinn 
et al., 2011). Bacteria also have the ability to transfer 
genetic material that is regulating antibiotic resistance 
genes to other bacteria that infect animals or human, 
transforming susceptible bacteria to resistant and pos-
ing great concern for their health (Quinn et al., 2011; 
OIE, 2016). The transformation of a sensitive E.coli 
bacterium to a resistant one can occur either by genetic 
mutations, or transformation of genetic material like 
plasmids (Gyles, 2008; Fricke et al., 2009; Dheilly et 
al., 2013) between two bacterial cells horizontally. 
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The trends antibioresistance for E.coli strains vary 
from country to another country according to world-
wide use of antibiotics and has become a field of re-
search for many projects. 
In a survey performed in Morroco, E.coli isolates 
from coliseptisemic birds revealed high resistance for 
sulphonamides, oxytetracycline, trimethoprim & sul-
phamethoxazole and chloramphenicol (Amara et al., 
1995). 
American scientists tried to investigate the antimi-
crobial patterns of avian E.coli strains isolated from 
broiler chickens suffering with colibacillosis (Zhao 
et al., 2005). It came out that the highest resistance 
levels were traced for sulfamethoxazole (93%), tet-
racycline (87%), streptomycin (86%) and gentamicin 
(69%). Furthermore, a high percentage of the isolates 
(92%) was proved to be multi-resistant (Zhao et al., 
2005). 
In a similar Chinese research project, the tested 
E.coli strains showed high levels of resistance to tet-
racycline (97.5%), nalidixic acid (82.3%), ampicil-
lin (81.1%), sulphafurazole (80.7%), streptomycin 
(79.0%), trimethoprim (78.2%) and cotrimoxazole 
(78.2%). Most of these strains (80.2%) were resist-
ant to more than 3 antimicrobial classes (Dou et al., 
2016). 
A survey that was conducted in India, revealed 
high E.coli resistance to chlortetracycline (88.58%), 
streptomycin (85.72%), penicillin-G (82.86%), ami-
kacin (82.86%), furazolidone (77.14%), ampicillin 
(74.29%) and tetracycline (74.29%) (Sahoo et al., 
2012) while an Iranian survey revealed high resist-
ance of broiler E.coli strains(>80%) for many differ-
ent antimicrobials (Salehi and Bonab, 2006).
Antibioresistance was traced even also for antimi-
crobials that were not supposed to be used. Resistance 
against cephalosporines in broilers which are not al-
lowed to be used in Belgium since 2000 was recorded 
in broilers (Smet et al., 2008). 
EU has also set a monitoring program for con-
trolling of E. coli infection in poultry, as all participat-
ing member countries must report their data especial-
ly for broiler chickens and turkeys. In Table (2), the 
antimicrobial resistance EU data for 2014 in broilers 
are shown in comparison to Greek data (Valkanou, 
2016; EFSA, 2016).
Table 2. Antimicrobial resistance to different antimicrobials in broilers (EFSA journal, 2016)
TYPE OF ANTIMICROBIAL %RESISTANCE EU %RESISTANCE GREECE
Ciprofloxacin 65.7 89












Multi drug resistance 54.6 49.1
* The European Union reported information includes data from 27 countries belonging to European Union plus Norway. 
The table reports a big variation of resistance 
among different classes where high resistance is 
observed to some antimicrobials (ciprofloxacin, na-
lixidic acid, ampicillin, sulfamethoxasole, tetracy-
cline and very low resistance to others (tigecycline, 
colistin). Resistance to cephalosporins was observed 
to be low in general, even though there were reports 
of higher levels of resistance in some countries (Cy-
prus, Latvia, Lithuania, Malta, Spain) (EFSA, 2016). 
E.coli strains with multidrug resistance reached the 
overall level 54.6% following a trend of increasing 
resistance. However, antibiotic resistance of indicator 
E.coli varied among different countries. For example, 
Scandinavian countries (Norway, Sweden, Denmark 
and Finland) revealed low resistance levels for most 
antimicrobial classes (EFSA, 2016).
Resistance to colistin, was reported to be restricted 
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(0.9%) in total while no resistance was observed in 
Greece. The discovery of the mcr-1 gene, that is re-
sponsible for bacterial resistance to colistin, is located 
on a plasmid and can transfer to other bacteria has in-
creased concern for colistin resistance spreading (Liu 
et al., 2015).
Since colistin is used as a last resort treatment for 
serious human diseases caused by Gram negative 
bacteria like (Enterobacteriacae, Acinetobacter, Pseu-
domonas) when other antimicrobial treatments prove 
to be ineffective, its sensitivity is crucial for human 
Medicine (Falagas and Kasiakou, 2005). Since 2014, 
EU has decided to apply a monitoring schedule for 
colistin resistance which was updated with a sur-
veillance scheme for the mcr-1 presence as well for 
bacteria like Escherichia coli and Salmonella (EFSA, 
2016).
 ALTERNATIVE CONTROL STRATEGIES
 Since antibioresistance is increasing, it is neces-
sary to adopt alternative measures and implement new 
tools and methodologies in order to control bacterial 
diseases. As many strains of E.coli are harboring in the 
bird’s intestinal tract, compounds that can control the 
gut overpopulation with E.coli can be useful against 
colibacillosis. The term ‘competitive exclusion’ has 
also been introduced to describe their mechanism.
Probiotics and prebiotics proved their efficacy 
against colibacillosis (Patterson and Burkholder, 
2003). 
Probiotics are microorganisms that belong mainly 
to the Bacillus family (Lactobacillus, Bacillus, Bifidus 
and Enterococcus) and the yeasts/moulds family (As-
pergillus/Candida). Probiotics proved their positive 
effect in improving the bird’s health by minimizing 
pathogenic bacterial intestinal colonization, produc-
ing antagonist pathogen metabolites and stimulating 
the immune response (Kabir, 2009; Papatsiros et al, 
2013; Wang et al., 2017). Jaiswal et al. (2019) showed 
that the use of Lactobacillus reuteri can reduce the 
pathogenic bacterial population including E.coli in 
broiler intestine. Similar findings of decreased caecal 
E.coli counts in broilers after the use of probiotics eas 
revealed by Salim et al.(2013). Two similar projects 
by Dong et al. (2019) and Cao et al. (2013) revealed 
the beneficial effect of a probiotic (Enterococcus fea-
calis) supplementation in broilers diet. The use of pro-
biotic contributed in the reduction of E.coli numbers 
in broilers intestine, after challenge with E.coli-K88.
Prebiotics are nutritional substances that are not 
digested and are necessary for the survival of specific 
intestinal bacteria which help the normal functioning 
of intestinal microflora (Hazati and Rezaei, 2010). 
The two main categories of prebiotics are fructo-ol-
igosaccharides and Mannan-oligosaccharides (Hazati 
and Rezaei, 2010). Prebiotics are adjusting the type 
and number of poultry beneficial microflora in com-
parison to pathogenic bacteria and also stimulate the 
bird immune system (Pourabedim and Zhao, 2015). 
Xu et al. (2003) managed to reduce the E.coli popu-
lation in broilers intestine after the use of fructo-oli-
gosaccharide in their diet. Kim et al. (2011) showed 
that the use of fructo-oligosaccharide (FOS) and man-
nan-oligosaccharide (MOS) in broilers’ diet managed 
to decrease significantly the number of E.coli in the 
gut.
Some essential oils are also found to to reduce the 
number of E.coli in the gut (Hammer et al., 1999). 
Ebani et al. (2018) tested the antimicrobial activity 
of 16 essential oils against and reported good activ-
ity for at least 5 oils against E.coli isolates deriving 
from poultry. Another study from Iran tried to test the 
efficacy of different essential oils coming from plants 
extracts. Some of the tested essential oils were proved 
to have antimicrobial activity against E.coli (Habibi 
et al., 2018)
 Acidifiers or organic acids can decrease the num-
ber of E.coli by changing the intestinal PH and conse-
quently reducing the intestinal pathogens metabolism, 
as well as by adjusting the population of beneficial 
bacteria (Khan and Iqbal, 2016). Furthermore, it has 
been found that organic acids can trigger the birds’ 
immunity (Khan and Iqbal, 2016). Emami et al. 
(2017) investigated the antimicrobial activity of or-
ganic acids after E.coli K88 challenge in broilers and 
showed that the use of 3 commercial organic acids 
managed to reduce the E.coli counts in ceca. Final-
ly, another study revealed that the use of a product 
consisting of formic acid, acetic acid and propionic 
acid contributed in the reduction of E.coli that was 
resistant to ampicillin, tetracycline, ciprofloxacin and 
sulfamethoxazole (Roth et al., 2017).
Another tool for controlling E. coli infection is 
the use of viruses which destruct the bacterial cells 
or bacteriophages. Bacteriophages can be naturally 
found in the environment and found to have an ef-
ficacy in colibacillosis control (Barrow et al., 1998; 
Huff et al, 2002; Huff et al., 2003 and 2004; Brussow, 
2005; Huff et al., 2005 and 2006). 
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Good hygiene practice in the hatchery reduces sig-
nificantly the risk of new hatcher birds with ompha-
litis. Rejection of dirty eggs containing large number 
of coliforms on their outer shell is a first step for min-
imizing hatchery infections. Spraying hatching eggs 
with disinfectants reduces contamination of egg sur-
face with E. coli (Barnes et al., 2008) and also using 
of ultraviolet light was found to limit the possibility of 
E. coli infection in chicks (Coufal et al., 2003). 
Maintaining optimum environmental conditions 
inside poultry house (air quality, temperature or stock-
ing density) maintaining a good health status as well 
as the application of a novel vaccination scheme min-
imize the risk of predisposing factors that are usually 
trigger colibacillosis outbreaks (Barnes et al., 2008).
Apart from all the above, vaccination against coli-
bacillosis is the most interesting tool as an alternative 
mean of control of colibacillosis. Live, subunit and 
inactivated vaccines have been tested to prevent E. 
coli infection in poultry (Ghunaim et al., 2014). Live 
vaccines are used in commercial poultry and they are 
administrated by mass applying route like spraying 
and seem to offer a wider protection against differ-
ent serotypes (Ghunaim et al., 2014). Subunit vac-
cines are applied by injection as they contain proteins 
(E.coli virulence factors) and seem to produce better 
heterologous immunity than inactivated vaccines. In-
activated vaccines also taken by injection and have 
strict homologous protection as they contain more 
than one strain of E. coli (Ghunaim et al., 2014). Vac-
cines mainly trigger a cell mediated immunity against 
E.coli challenge as this type of immunity plays the 
most important role in bird’s protection when com-
pared with humoral immunity and antibodies (Filho 
et al., 2013; Sadeyen et al., 2014 and 2015).
Live vaccines to control E. coli infection in poultry 
have been tested in Germany (Heydel et al., 2019b), 
in Italy and USA (Alberti et al., 2019), in Taiwan (Lee 
Guo-Wei et al., 2019), in Japan (Nagano et al., 2012), 
in USA (Cookson et al., 2008), in the UK (La Ragi-
one et al., 2013), in Morocco (Mombarg et al., 2014), 
in Iran (Sadeghi et al., 2018) and in Israel (Frommer 
et al., 1994) and the results revealed that this type of 
vaccine reduced mortality, macroscopic lesions of 
colibacillosis and in some cases diminished bacteri-
al recovery after challenge with E.coli strains. Live 
E.coli vaccines have also been reported to reduce 
mortality and increase egg laying rates in layer breed-
ers in Japan (Asano et al., 2019; Uotani et al., 2017) 
and in Thailand (Awaiwanont and Chotinum, 2019) 
where the E.coli vaccination also reduced the applied 
antibiotic treatment.
However, another study showed that live E. coli 
vaccines could not control colibacillosis after homol-
ogous or heterologous challenge (Kariyawasam et al., 
2004). 
Inactivated E.coli vaccines have already been re-
ported to be beneficial in experimental trials. A Cana-
dian study tested the efficacy of inactivated vaccines 
with different adjuvants and found reduced recovery 
of the challenging E.coli in comparison to unvacci-
nated birds (Gomis et al., 2007). Yaguchi et al. (2009) 
reported that the use of an inactivated liposomal E.co-
li vaccine managed to reduce clinical symptoms and 
bacterial numbers in chicken blood after E.coli chal-
lenge of specific pathogen free chickens.
Another survey tried to evaluate the benefits con-
ferred by a commercial inactivated vaccine to broiler 
breeders and their progeny. A broiler breeder flock 
was divided in 2 groups of birds. Half of the birds 
were vaccinated with a commercial inactivated E.coli 
vaccine while the rest birds received no vaccination 
against E.coli. Even though, overall mortality be-
tween the 2 groups was similar, the vaccinated group 
was reported to have reduced losses due to colibacil-
losis in comparison to the unvaccinated group of birds 
(Gregersen et al., 2010).
Shehata et al. (2019) investigated the efficacy of a 
formalin inactivated E.coli vaccine that consisted of 
7 different APEC serotypes, after challenge of SPF 
chicks. The efficacy was assessed by means of mortal-
ity, clinical signs and seroconversion. It was observed 
that the vaccinated birds were 100% protected when 
challenged with an O157:H7 and partially protected 
after an O125 challenge.
Autogenous vaccines are another type of vaccines 
that are used with increasing interest against E. coli 
infections. The term autogenous vaccine is used to 
describe vaccines that are produced specifically to 
protect a certain flock. Their production procedure 
uses bacterial isolates from a specific flock suffering 
from colibacillosis and produces a vaccine contain-
ing the homologous E.coli strains of the flock. Those 
vaccines may delay the clinical onset of colibacillosis 
and reduce mortality.
Landman and Eck (2017b) demonstrated complete 
protective effect of autogenous vaccines after aerosol 
homologous challenge with pathogenic E.coli in layer 
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hens. However, protection was not proved after het-
erologous challenge. The efficacy of an autogenous 
vaccine has also been reported after homologous in-
tratracheal challenge in layer pullets in a Greek study 
(Koutsianos et al., 2019). Another Egyptian study 
showed reduced mortalities in E. coli challenged 
birds after vaccination with an autogenous vaccine 
(El Jakee et al., 2016). On the other hand, there are 
reports of incomplete protective efficacy of using au-
togenous vaccines against E.coli challenges (Li et al., 
2016). The authors reported that the reasons for this 
may be the high infective dose that was used or the 
insufficiency of the stimulating humoral immunity to 
confer protection against E.coli challenge. 
So, vaccines seem to be an interesting tool against 
colibacillosis and also contributing in the limitation 
of treatment with antimicrobials. However, there are 
still some cases with weak vaccine protection against 
colibacillosis. Further investigations related to avian 
E. coli vaccine production, and efficacy are in need.
CONCLUSIONS
Colibacillosis is the most common bacterial dis-
ease in poultry having great economic significance 
for the producers. Disease controlling using antimi-
crobials has led to the emergence of antibioresistance 
creating a big concern for animal and human health. 
It is crucial that judicious use of antimicrobials will 
be combined with a different approach for controlling 
colibacillosis including various preventing measures 
along with alternative treatments. Vaccination can 
have an important role in the control of the disease.
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